Summary GlobalData’s new report, Canada Genetic Testing Market Outlook to 2024, provides key market data on the Canada Genetic Testing market. The report provides value, in millions of US dollars within market segments - Acquired Gene or Chromosome Alterations, Inborn Gene or Chromosome Alterations and Other Genetic Tests
The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.
Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.
Scope - Market size and company share data for Genetic Testing market segments - Acquired Gene or Chromosome Alterations, Inborn Gene or Chromosome Alterations and Other Genetic Tests - Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2010 to 2017 and forecast to 2024. - 2017 company shares and distribution shares data for each of the market segments. - Global corporate-level profiles of key companies operating within the Canada Genetic Testing market. - Key players covered include F. Hoffmann-La Roche Ltd, Abbott Laboratories and Luminex Corp.
Reasons to buy - Develop business strategies by identifying the key market segments poised for strong growth in the future. - Develop market-entry and market expansion strategies. - Design competition strategies by identifying who-stands-where in the market. - Develop investment strategies by identifying the key market segments expected to register strong growth in the near future. - What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
Our reports have been used by over 10K customers, including:
The POC data management software market was valued at USD 5916.9 million in 2019, and it is expected to reach a value of USD 11,772.2 million by 2025, registering a CAGR of 12.3% over the forecast period from 2020 to 2025. Point-of-care technologies enable hospitals and clinics to invest more time and money in technologies that help accelerate...
Good genes: Improved technology and declining costs will likely foster industry revenue growth Abstract DNA & DNA Forensic Laboratories Over the past five years, the DNA and DNA Forensic Laboratories industry has benefited from improved accessibility and declining prices, which have made DNA testing...
The global point of care diagnostrics market size is projected to reach USD 50.6 billion by 2025 from USD 29.5 billion in 2020, at a CAGR of 11.4%. Factors such as the technological advancements in point of care devices in the market are propelling the growth of the market. Additionally, rising cases of investments from both private and public...
Summary Biocartis Group NV (Biocartis) operates as a molecular diagnostics company that provides personalized medicine for patients through its molecular diagnostics.The company undertakes the development of diagnostics technology platforms for multiplexed detection of bio-analytes, with oncology as its key focus area. Its...
The women’s health diagnostics market is projected to reach USD 36.6 billion by 2025 from USD 25.0 billion in 2020, at a CAGR of 7.9% during the forecast period. In the past decade, the demand for various health diagnostic tests has increased significantly across the globe. Currently, the market is mainly driven by growing awareness about...
The global chromatography instruments market is projected to reach USD 11.0 billion by 2025 from USD 8.6 billion in 2020 at a CAGR of 5.1%. Growth in the chromatography instruments market can be attributed to increasing investments by pharma and biotech companies in R&D activities, growing demand for hyphenated chromatography techniques, and...
The major factors responsible for the growth of the mammography market include the growing prevalence of breast cancer, technological advancements in the field of breast imaging, and investment from various organizations in breast cancer screening campaigns. - According to the Centers for Disease Control and Prevention (CDC) reports,...
Thyroid Function Tests - Medical Devices Pipeline Assessment, 2020
Summary
Medical Devices sector report, “Thyroid Function Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Thyroid Function Tests pipeline products with comparative analysis of the...
Cardiac Marker Tests - Medical Devices Pipeline Assessment, 2020
Summary
Medical Devices sector report, “Cardiac Marker Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Cardiac Marker Tests pipeline products with comparative analysis of the products...
212 pages •
By Asia Market Information & Development Company
• Feb 2021
China’s demand for Patient Monitoring and Diagnostic Systems has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import...
Patient Monitoring
Diagnostics
China
Industrial Production
Labour Force
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.